These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38626321)

  • 1. Pandemics, intellectual property and 'our economy': A worldview analysis of Canada's role in compromising global access to COVID-19 vaccines.
    Brisbois B; Plamondon K; Walugembe D; Pereira RC; Edet C; Dixon J; Habibi R; Karamouzian M; Labonté R; Murthy S; Ravitsky V
    Glob Public Health; 2024 Jan; 19(1):2335360. PubMed ID: 38626321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Global Intellectual Property Waiver is Still Needed to Address the Inequities of COVID-19 and Future Pandemic Preparedness.
    Amin T; Kesselheim AS
    Inquiry; 2022; 59():469580221124821. PubMed ID: 36124939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biopharmaceutical Financialization and Public Funding of Medical Countermeasures (MCMs) in Canada During the COVID-19 Pandemic.
    Eren Vural I; Herder M; Doll A; Graham JE
    Int J Health Policy Manag; 2023; 12():6936. PubMed ID: 37579382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Designing the global vaccine supply chain: balancing intellectual property rights with post COVID-19 vaccine equity.
    Park SP; Lee HJ; Yu Y; Lee EYJ; Park YS
    BMJ Glob Health; 2023 Nov; 8(11):. PubMed ID: 38035734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canada's global health role: supporting equity and global citizenship as a middle power.
    Nixon SA; Lee K; Bhutta ZA; Blanchard J; Haddad S; Hoffman SJ; Tugwell P
    Lancet; 2018 Apr; 391(10131):1736-1748. PubMed ID: 29483026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is Intellectual Property the COVID-19 Bad Guy? Lessons We Could Learn from the Pandemic.
    Lawson C
    J Law Med; 2023 Dec; 30(3):538-554. PubMed ID: 38332594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An equitable vaccine delivery system: Lessons from the COVID-19 vaccine rollout in Canada.
    Kholina K; Harmon SHE; Graham JE
    PLoS One; 2022; 17(12):e0279929. PubMed ID: 36584230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International Collaboration to Ensure Equitable Access to Vaccines for COVID-19: The ACT-Accelerator and the COVAX Facility.
    Eccleston-Turner M; Upton H
    Milbank Q; 2021 Jun; 99(2):426-449. PubMed ID: 33650737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inequitable COVID-19 vaccine distribution and the intellectual property rights prolong the pandemic.
    Altindis E
    Expert Rev Vaccines; 2022 Apr; 21(4):427-430. PubMed ID: 34878957
    [No Abstract]   [Full Text] [Related]  

  • 10. Canada and access to medicines in developing countries: intellectual property rights first.
    Lexchin J
    Global Health; 2013 Sep; 9():42. PubMed ID: 24007595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the institutional landscape and proliferation of proposals for global vaccine equity for COVID-19: too many cooks or too many recipes?
    Geiger S; McMahon A
    J Med Ethics; 2023 Aug; 49(8):583-590. PubMed ID: 34848492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Public opinion on global COVID-19 vaccine procurement and distribution policies: A nationally representative survey in Aotearoa New Zealand 2022.
    Kolandai K; Milne B; von Randow M; Bullen C; Marsh S; Crump JA
    Vaccine; 2024 Feb; 42(6):1372-1382. PubMed ID: 38326132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Policy responses to COVID-19: lessons for the global trade and investment regime.
    Thrasher R; Kaplan W; Wirtz VJ; Clear L; Bodduluri SP; Polaski S
    Global Health; 2023 Sep; 19(1):66. PubMed ID: 37658444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intellectual property waiver for covid-19 vaccines will advance global health equity.
    Erfani P; Binagwaho A; Jalloh MJ; Yunus M; Farmer P; Kerry V
    BMJ; 2021 Aug; 374():n1837. PubMed ID: 34344728
    [No Abstract]   [Full Text] [Related]  

  • 15. Can we move beyond vaccine apartheid? Examining the determinants of the COVID-19 vaccine gap.
    Forman L; Jackson C; Fajber K
    Glob Public Health; 2023 Jan; 18(1):2256822. PubMed ID: 37715686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disability-a chronic omission in health equity that must be central to Canada's post-pandemic recovery.
    Downer MB; Rotenberg S
    Health Promot Chronic Dis Prev Can; 2023 Jun; 43(6):348-351. PubMed ID: 37466400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19-related global health governance and population health priorities for health equity in G20 countries: a scoping review.
    Mac-Seing M; Gidey M; Di Ruggiero E
    Int J Equity Health; 2023 Nov; 22(1):232. PubMed ID: 37924074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations for Canada's National Action Plan to End Gender-Based Violence: perspectives from leaders, service providers and survivors in Canada's largest city during the COVID-19 pandemic.
    Yakubovich AR; Steele B; Moses C; Tremblay E; Arcenal M; O'Campo P; Mason R; Du Mont J; Huijbregts M; Hough L; Sim A; Shastri P
    Health Promot Chronic Dis Prev Can; 2023 Apr; 43(4):155-170. PubMed ID: 36651882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine nationalism is not unethical from a political ethics perspective: Learning from the global COVID-19 vaccine distribution failure.
    Shao Q
    Health Policy; 2024 Mar; 141():104996. PubMed ID: 38266331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scaling Up the Global COVID-19 Vaccination Program: Production, Allocation, and Distribution with an Emphasis on Equity.
    Louden EM
    Yale J Biol Med; 2022 Sep; 95(3):379-387. PubMed ID: 36187418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.